{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:05:24Z","timestamp":1789549524602,"version":"build-2803163510"},"reference-count":123,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Reprod Med"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Perimenopausal women have specific needs when it comes to contraception. Although fertility rates generally decrease after age 40, pregnancy is still possible and may be associated with a higher risk of obstetric and fetal complications. Moreover, women may experience bothersome symptoms during perimenopause due to anovulatory cycles and fluctuating estrogen levels, such as abnormal uterine bleeding, vasomotor symptoms, migraines, and mood disorders. Additionally, age increases the risk of the most common side effects of well-known contraceptives, particularly those containing estrogen. For this reason, contraception counseling during perimenopause should be tailored to the woman's characteristics. It should include three steps: evaluating the woman's needs and symptoms; evaluating the potential benefits of the chosen method; evaluating risk factors that may contraindicate certain choices. No contraceptive method is contraindicated solely based on age. Among combined hormonal contraceptives, if no contraindication exists, natural estrogens should be preferred after 40 years old. On the other hand, progestin-only methods can also be safely used in the presence of cardiovascular risk factors. This review will address the main reasons why a woman may need an HC method and how to make a tailored and informed choice.<\/jats:p>","DOI":"10.1055\/s-0045-1811951","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T22:53:46Z","timestamp":1758322426000},"page":"134-144","source":"Crossref","is-referenced-by-count":3,"title":["Hormonal Contraception in Perimenopause: What to Consider to Guide the Choice"],"prefix":"10.1055","volume":"43","author":[{"given":"Tiziana","family":"Fidecicchi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"},{"name":"Health Science Interdisciplinary Center, Sant'Anna School of Advanced Studies, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Caretto","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Simi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Montt Guevara","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giannini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Luisi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Simoncini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"issue":"05","key":"ref1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/humrep\/dez015","article-title":"Variations in reproductive events across life: a pooled analysis of data from 505 147 women across 10 countries","volume":"34","author":"InterLACE Study Team","year":"2019","journal-title":"Hum Reprod"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"h5746","DOI":"10.1136\/bmj.h5746","article-title":"Diagnosis and management of menopause: summary of NICE guidance","volume":"351","author":"G Sarri","year":"2015","journal-title":"BMJ"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697137.2015.1129166","article-title":"2016 IMS recommendations on women's midlife health and menopause hormone therapy","volume":"19","author":"R J Baber","year":"2016","journal-title":"Climacteric"},{"issue":"19","key":"ref4","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1016\/j.cell.2023.08.016","article-title":"Menopause-biology, consequences, supportive care, and therapeutic options","volume":"186","author":"S R Davis","year":"2023","journal-title":"Cell"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/clinem\/dgaa764","article-title":"The menopause transition: signs, symptoms, and management options","volume":"106","author":"N Santoro","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrendo.2017.180","article-title":"Symptoms of menopause - global prevalence, physiology and implications","volume":"14","author":"P Monteleone","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/13697137.2018.1540566","article-title":"Overview of perimenopausal contraception","volume":"22","author":"J Bitzer","year":"2019","journal-title":"Climacteric"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.fertnstert.2015.03.004","article-title":"Reproduction at an advanced maternal age and maternal health","volume":"103","author":"M V Sauer","year":"2015","journal-title":"Fertil Steril"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/jc.2011-3362","article-title":"Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging","volume":"97","author":"S D Harlow","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1210\/jc.2002-021839","article-title":"Impaired folliculogenesis and ovulation in older reproductive aged women","volume":"88","author":"N Santoro","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/gme.0b013e31823b0b2e","article-title":"Ovarian primordial and nongrowing follicle counts according to the stages of reproductive aging workshop (STRAW) staging system","volume":"19","author":"K R Hansen","year":"2012","journal-title":"Menopause"},{"issue":"03","key":"ref12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ecl.2015.05.010","article-title":"Endocrinology of the menopause","volume":"44","author":"J E Hall","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2010.08.059","article-title":"Neurokinin B and the hypothalamic regulation of reproduction","volume":"1364","author":"N E Rance","year":"2010","journal-title":"Brain Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(17)30823-1","article-title":"Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"389","author":"J K Prague","year":"2017","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1038\/srep08466","article-title":"Neurokinin B administration induces hot flushes in women","volume":"5","author":"C N Jayasena","year":"2015","journal-title":"Sci Rep"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABA(A) receptor","volume":"6","author":"D Belelli","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"108087","DOI":"10.1016\/j.maturitas.2024.108087","article-title":"Neuroendocrine mechanisms of mood disorders during menopause transition: a narrative review and future perspectives","volume":"188","author":"T Fidecicchi","year":"2024","journal-title":"Maturitas"},{"issue":"05","key":"ref18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.contraception.2011.07.013","article-title":"Unintended pregnancy in the United States: incidence and disparities, 2006","volume":"84","author":"L B Finer","year":"2011","journal-title":"Contraception"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"102975","DOI":"10.1016\/j.midw.2021.102975","article-title":"Factors associated with giving birth at advanced maternal age in the United States","volume":"98","author":"S I Maloney","year":"2021","journal-title":"Midwifery"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/01.AOG.0000140682.63746.be","article-title":"Advanced maternal age and adverse perinatal outcome","volume":"104","author":"B Jacobsson","year":"2004","journal-title":"Obstet Gynecol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1126\/science.aav7321","article-title":"Chromosome errors in human eggs shape natural fertility over reproductive life span","volume":"365","author":"J R Gruhn","year":"2019","journal-title":"Science"},{"issue":"06","key":"ref22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1515\/mr-2022-0031","article-title":"Ovarian aging: mechanisms and intervention strategies","volume":"2","author":"Z Zhu","year":"2022","journal-title":"Med Rev (Berl)"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.20344\/amp.11057","article-title":"Advanced maternal age: adverse outcomes of pregnancy, a meta-analysis","volume":"32","author":"R L Pinheiro","year":"2019","journal-title":"Acta Med Port"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.maturitas.2016.02.008","article-title":"Do women aged over 40 need different counseling on combined hormonal contraception?","volume":"87","author":"N Mendoza","year":"2016","journal-title":"Maturitas"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.maturitas.2013.07.009","article-title":"Contraception during the perimenopause","volume":"76","author":"M K Baldwin","year":"2013","journal-title":"Maturitas"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1097\/GME.0000000000002072","article-title":"Perimenopause meets life: observations from the women living better survey","volume":"29","author":"N F Woods","year":"2022","journal-title":"Menopause"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2005.09.031","article-title":"Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives","volume":"118","author":"N F Woods","year":"2005","journal-title":"Am J Med"},{"issue":"21","key":"ref28","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.2019.5248","article-title":"Abnormal uterine bleeding in reproductive-age women","volume":"321","author":"A M Kaunitz","year":"2019","journal-title":"JAMA"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"M G Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"issue":"03","key":"ref30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijgo.12666","article-title":"The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions","volume":"143","author":"M G Munro","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"2362244","DOI":"10.1080\/09513590.2024.2362244","article-title":"Unmet needs in abnormal uterine bleeding due to ovulatory dysfunction","volume":"40","author":"T Simoncini","year":"2024","journal-title":"Gynecol Endocrinol"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/GME.0000000000000676","article-title":"Characterizing the trajectories of vasomotor symptoms across the menopausal transition","volume":"23","author":"P G Tepper","year":"2016","journal-title":"Menopause"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e072612","DOI":"10.1136\/bmj-2022-072612","article-title":"Management of perimenopausal and menopausal symptoms","volume":"382","author":"E R Duralde","year":"2023","journal-title":"BMJ"},{"issue":"03","key":"ref34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ogc.2011.06.002","article-title":"Sleep during the perimenopause: a SWAN story","volume":"38","author":"H M Kravitz","year":"2011","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"08","key":"ref35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/GME.0000000000001793","article-title":"Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden","volume":"28","author":"R E Nappi","year":"2021","journal-title":"Menopause"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0140-6736(23)00085-5","article-title":"Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study","volume":"401","author":"S Lederman","year":"2023","journal-title":"Lancet"},{"issue":"16","key":"ref38","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/jama.2024.14618","article-title":"Elinzanetant for the treatment of vasomotor symptoms associated with menopause: OASIS 1 and 2 randomized clinical trials","volume":"332","author":"J V Pinkerton","year":"2024","journal-title":"JAMA"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1161\/STROKEAHA.116.014674","article-title":"Menopausal hot flashes and carotid intima media thickness among midlife women","volume":"47","author":"R C Thurston","year":"2016","journal-title":"Stroke"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/STROKEAHA.115.010600","article-title":"Trajectories of vasomotor symptoms and carotid intima media thickness in the study of women's health across the nation","volume":"47","author":"R C Thurston","year":"2016","journal-title":"Stroke"},{"issue":"04","key":"ref41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/13697137.2016.1191459","article-title":"Vasomotor symptoms and cardiometabolic risk factors in menopausal women: a MONET group study","volume":"19","author":"J Abdulnour","year":"2016","journal-title":"Climacteric"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.maturitas.2023.05.004","article-title":"Menopausal symptoms and cardiometabolic risk factors in middle-aged women: a cross-sectional and longitudinal study with 4-year follow-up","volume":"174","author":"M Hyv\u00e4rinen","year":"2023","journal-title":"Maturitas"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(23)02799-X","article-title":"An empowerment model for managing menopause","volume":"403","author":"M Hickey","year":"2024","journal-title":"Lancet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(23)02801-5","article-title":"Promoting good mental health over the menopause transition","volume":"403","author":"L Brown","year":"2024","journal-title":"Lancet"},{"issue":"01","key":"ref45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1749-6632.2009.04982.x","article-title":"Sex hormones and mood in the perimenopause","volume":"1179","author":"P J Schmidt","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pneurobio.2013.07.005","article-title":"Allopregnanolone and mood disorders","volume":"113","author":"T B\u00e4ckstr\u00f6m","year":"2014","journal-title":"Prog Neurobiol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"104512","DOI":"10.1016\/j.psyneuen.2019.104512","article-title":"The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause","volume":"112","author":"A Kimball","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"928143","DOI":"10.3389\/fendo.2022.928143","article-title":"Current perspectives on Kisspeptins role in behaviour","volume":"13","author":"E G Mills","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/gme.0b013e31817b816e","article-title":"Trend in incidence of osteoporosis-related fractures among 40- to 69-year-old women: analysis of a large insurance claims database, 2000-2005","volume":"16","author":"S Islam","year":"2009","journal-title":"Menopause"},{"issue":"04","key":"ref50","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ecl.2024.08.008","article-title":"Postmenopausal Osteoporosis: a review of latest guidelines","volume":"53","author":"P Subarajan","year":"2024","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"12","key":"ref51","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.3390\/jcm12124042","article-title":"Managing early onset osteoporosis: the impact of premature ovarian insufficiency on bone health","volume":"12","author":"B Meczekalski","year":"2023","journal-title":"J Clin Med"},{"issue":"09","key":"ref52","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/GME.0000000000001831","article-title":"Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society","volume":"28","author":"North American Menopause Society","year":"2021","journal-title":"Menopause"},{"issue":"06","key":"ref53","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2213-8587(22)00076-6","article-title":"Menopause: a cardiometabolic transition","volume":"10","author":"R E Nappi","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"07","key":"ref54","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/ehn018","article-title":"Risk factors for myocardial infarction in women and men: insights from the InterHeart study","volume":"29","author":"S S Anand","year":"2008","journal-title":"Eur Heart J"},{"issue":"02","key":"ref55","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/jwh.2023.0003","article-title":"The association of early menopause with increased risk of acute myocardial infarction: the InterHeart China study","volume":"33","author":"T Liu","year":"2024","journal-title":"J Womens Health (Larchmt)"},{"issue":"08","key":"ref56","doi-asserted-by":"crossref","first-page":"e0255913","DOI":"10.1371\/journal.pone.0255913","article-title":"Contraceptive use among women through their later reproductive years: Findings from an Australian prospective cohort study","volume":"16","author":"M L Harris","year":"2021","journal-title":"PLoS One"},{"issue":"02","key":"ref58","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/dc16-1534","article-title":"Hormonal contraception and risk of thromboembolism in women with diabetes","volume":"40","author":"S H O'Brien","year":"2017","journal-title":"Diabetes Care"},{"issue":"05","key":"ref59","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.122.20018","article-title":"Oral contraceptive pills and hypertension: a review of current evidence and recommendations","volume":"80","author":"N A Cameron","year":"2023","journal-title":"Hypertension"},{"issue":"06","key":"ref60","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/ehf2.14104","article-title":"Obesity and contraceptive use: impact on cardiovascular risk","volume":"9","author":"G MC Rosano","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"05","key":"ref61","doi-asserted-by":"crossref","first-page":"e124865","DOI":"10.1172\/jci.insight.124865","article-title":"Changes in body composition and weight during the menopause transition","volume":"4","author":"G A Greendale","year":"2019","journal-title":"JCI Insight"},{"issue":"04","key":"ref62","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.contraception.2015.01.011","article-title":"Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices","volume":"91","author":"K Heinemann","year":"2015","journal-title":"Contraception"},{"issue":"01","key":"ref63","doi-asserted-by":"crossref","first-page":"2247093","DOI":"10.1080\/09513590.2023.2247093","article-title":"Hormonal and natural contraceptives: a review on efficacy and risks of different methods for an informed choice","volume":"39","author":"A R Genazzani","year":"2023","journal-title":"Gynecol Endocrinol"},{"issue":"21","key":"ref64","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"B Winner","year":"2012","journal-title":"N Engl J Med"},{"issue":"05","key":"ref65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0010-7824(98)00110-3","article-title":"Pharmacokinetics of etonogestrel released from the contraceptive implant implanon","volume":"58","author":"R Wenzl","year":"1998","journal-title":"Contraception"},{"issue":"01","key":"ref66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.contraception.2008.07.017","article-title":"Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis\u2013a pilot study","volume":"79","author":"K Walch","year":"2009","journal-title":"Contraception"},{"issue":"04","key":"ref67","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/humrep\/14.4.976","article-title":"A multicentre efficacy and safety study of the single contraceptive implant implanon","volume":"14","author":"H B Croxatto","year":"1999","journal-title":"Hum Reprod"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0b013e318259565a","article-title":"Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women","volume":"120","author":"H Xu","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"S 01","key":"ref69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13625180801959931","article-title":"The effects of Implanon on menstrual bleeding patterns","volume":"13","author":"D Mansour","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"06","key":"ref70","first-page":"CD006033","article-title":"Steroidal contraceptives: effect on bone fractures in women","volume":"2014","author":"L M Lopez","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"04","key":"ref71","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0010-7824(90)90035-T","article-title":"Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device","volume":"41","author":"B L Xiao","year":"1990","journal-title":"Contraception"},{"issue":"02","key":"ref72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.6118\/jmm.20038","article-title":"Levonorgestrel-releasing intrauterine system use in perimenopausal women","volume":"27","author":"J K Joo","year":"2021","journal-title":"J Menopausal Med"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajog.2015.07.044","article-title":"The medical management of abnormal uterine bleeding in reproductive-aged women","volume":"214","author":"L D Bradley","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"07","key":"ref74","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/14656566.2018.1462337","article-title":"Levonorgestrel-releasing intra-uterine systems as female contraceptives","volume":"19","author":"G Grandi","year":"2018","journal-title":"Expert Opin Pharmacother"},{"issue":"12","key":"ref75","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.jogc.2019.03.025","article-title":"Guideline no. 390-classification and management of endometrial hyperplasia","volume":"41","author":"M H Auclair","year":"2019","journal-title":"J Obstet Gynaecol Can"},{"issue":"09","key":"ref77","first-page":"CD012658","article-title":"Levonorgestrel-releasing intrauterine system for endometrial hyperplasia","volume":"9","author":"T Mittermeier","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"05","key":"ref78","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2217\/WHE.13.41","article-title":"Obesity and hormonal contraceptive efficacy","volume":"9","author":"J A Robinson","year":"2013","journal-title":"Womens Health (Lond Engl)"},{"issue":"01","key":"ref79","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/13625180903427675","article-title":"Efficacy of contraceptive methods: a review of the literature","volume":"15","author":"D Mansour","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"05","key":"ref80","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.contraception.2008.11.012","article-title":"Side effects from the copper IUD: do they decrease over time?","volume":"79","author":"D Hubacher","year":"2009","journal-title":"Contraception"},{"issue":"01","key":"ref81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.contraception.2009.02.005","article-title":"Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density","volume":"80","author":"A M Kaunitz","year":"2009","journal-title":"Contraception"},{"issue":"06","key":"ref82","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"N K Tepper","year":"2016","journal-title":"Contraception"},{"issue":"12","key":"ref83","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1007\/s00198-019-05103-6","article-title":"Bone health in estrogen-free contraception","volume":"30","author":"P Hadji","year":"2019","journal-title":"Osteoporos Int"},{"issue":"05","key":"ref84","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13625187.2024.2375285","article-title":"Inhibition ratio (I.R.) and transformation index (T.I.): new indexes to compare the effectiveness and clinical behaviour of modern progestin-only pills (POP)","volume":"29","author":"G Grandi","year":"2024","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"06","key":"ref85","first-page":"1994","article-title":"Drospirenone 4\u2009mg in a 24\/4 regimen maintains inhibition of ovulation even after a 24-h delay pill intake - pharmacological aspects and comparison to other progestin-only pills","volume":"26","author":"P A Regidor","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"04","key":"ref86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"A T Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"issue":"03","key":"ref87","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/GRF.0000000000000389","article-title":"Management of the perimenopause","volume":"61","author":"L Delamater","year":"2018","journal-title":"Clin Obstet Gynecol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study","volume":"346","author":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1995","journal-title":"Lancet"},{"issue":"04","key":"ref89","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1783\/147118910793048665","article-title":"50 years of \u201cthe pill\u201d: celebrating a golden anniversary","volume":"36","author":"A Szarewski","year":"2010","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"03","key":"ref90","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"M V Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume":"1043","author":"B T Palmisano","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"14","key":"ref92","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.2020.11935","article-title":"Hormonal contraception in women with hypertension","volume":"324","author":"C Shufelt","year":"2020","journal-title":"JAMA"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"1428597","DOI":"10.3389\/fendo.2024.1428597","article-title":"Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis","volume":"15","author":"J Douxfils","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"23","key":"ref94","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.3390\/jcm10235625","article-title":"Estetrol: a new choice for contraception","volume":"10","author":"F Fruzzetti","year":"2021","journal-title":"J Clin Med"},{"issue":"07","key":"ref95","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/17425255.2016.1190832","article-title":"Metabolic impact of combined hormonal contraceptives containing estradiol","volume":"12","author":"G Grandi","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"04","key":"ref96","first-page":"CD003552","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception","volume":"2013","author":"L M Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"01","key":"ref97","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beem.2012.09.004","article-title":"Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills","volume":"27","author":"R Sitruk-Ware","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"01","key":"ref98","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/13625187.2018.1435779","article-title":"Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"23","author":"M Amiri","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"05","key":"ref99","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/humupd\/dmv023","article-title":"Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods","volume":"21","author":"L Bahamondes","year":"2015","journal-title":"Hum Reprod Update"},{"issue":"07","key":"ref100","first-page":"CD004695","article-title":"Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception","volume":"2014","author":"A Edelman","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"04","key":"ref101","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3109\/13625187.2011.591456","article-title":"Effective treatment of heavy and\/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest","volume":"16","author":"I S Fraser","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"03","key":"ref102","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.contraception.2021.05.002","article-title":"Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results","volume":"104","author":"M D Creinin","year":"2021","journal-title":"Contraception"},{"issue":"01","key":"ref103","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/1471-0528.16840","article-title":"Estetrol-drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia","volume":"129","author":"K Gemzell-Danielsson","year":"2022","journal-title":"BJOG"},{"issue":"10","key":"ref104","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s40265-022-01738-8","article-title":"Estetrol\/drospirenone: a review in oral contraception","volume":"82","author":"A Lee","year":"2022","journal-title":"Drugs"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2147\/IJWH.S288070","article-title":"Contraception during perimenopause: practical guidance","volume":"14","author":"G Grandi","year":"2022","journal-title":"Int J Womens Health"},{"issue":"03","key":"ref106","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/13625187.2024.2334350","article-title":"Oestrogens in oral contraception: considerations for tailoring prescription to women's needs","volume":"29","author":"F Fruzzetti","year":"2024","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"01","key":"ref107","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clinthera.2011.11.006","article-title":"Estradiol valerate\/dienogest: a novel combined oral contraceptive","volume":"34","author":"L M Borgelt","year":"2012","journal-title":"Clin Ther"},{"issue":"04","key":"ref108","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00042192-200107000-00011","article-title":"A scheme of combined oral contraceptives for women more than 40 years old","volume":"8","author":"J E Bl\u00fcmel","year":"2001","journal-title":"Menopause"},{"issue":"04","key":"ref109","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2014.05.018","article-title":"Migraine and perimenopause","volume":"78","author":"K Ibrahimi","year":"2014","journal-title":"Maturitas"},{"issue":"01","key":"ref110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s10194-018-0896-5","article-title":"Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)","volume":"19","author":"S Sacco","year":"2018","journal-title":"J Headache Pain"},{"issue":"07","key":"ref111","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17512433.2020.1783247","article-title":"Drospirenone 4\u2009mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception","volume":"13","author":"M Chiara Del Savio","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"01","key":"ref112","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejogrb.2005.10.029","article-title":"Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)\u2013a systematic enquiry and overview","volume":"125","author":"R Varma","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"02","key":"ref113","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejogrb.2010.07.016","article-title":"Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause","volume":"152","author":"H Marret","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"08","key":"ref114","first-page":"CD006034","article-title":"Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use","volume":"8","author":"K Christelle","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"01","key":"ref115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bjsm.2005.020065","article-title":"Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review","volume":"40","author":"S L Liu","year":"2006","journal-title":"Br J Sports Med"},{"issue":"05","key":"ref116","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.contraception.2006.01.003","article-title":"Combined hormonal contraception and bone health: a systematic review","volume":"73","author":"S L Martins","year":"2006","journal-title":"Contraception"},{"issue":"07","key":"ref117","first-page":"CD009849","article-title":"Steroidal contraceptives and bone fractures in women: evidence from observational studies","volume":"2015","author":"L M Lopez","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"V Beral","year":"2008","journal-title":"Lancet"},{"issue":"06","key":"ref120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/humupd\/dmq022","article-title":"Hormonal contraception and risk of cancer","volume":"16","author":"D Cibula","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"05","key":"ref121","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/humupd\/dmp017","article-title":"Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis","volume":"15","author":"C Bosetti","year":"2009","journal-title":"Hum Reprod Update"},{"issue":"03","key":"ref122","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ygyno.2022.01.014","article-title":"Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation","volume":"164","author":"Y Y Xia","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"02","key":"ref123","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/09513590.2012.730579","article-title":"Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women","volume":"29","author":"M Morelli","year":"2013","journal-title":"Gynecol Endocrinol"},{"issue":"23","key":"ref124","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.3390\/cancers15235624","article-title":"Hormonal contraception and the risk of breast cancer in women of reproductive age: a meta-analysis","volume":"15","author":"L A Torres-de la Roche","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"03","key":"ref125","doi-asserted-by":"crossref","first-page":"e1004188","DOI":"10.1371\/journal.pmed.1004188","article-title":"Combined and progestagen-only hormonal contraceptives and breast cancer risk: a UK nested case-control study and meta-analysis","volume":"20","author":"D Fitzpatrick","year":"2023","journal-title":"PLoS Med"},{"issue":"23","key":"ref126","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"L S M\u00f8rch","year":"2017","journal-title":"N Engl J Med"},{"issue":"04","key":"ref127","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/13625187.2019.1604947","article-title":"Contraception in cancer survivors - an expert review part II. Skin, gastrointestinal, haematological and endocrine cancers","volume":"24","author":"A Cagnacci","year":"2019","journal-title":"Eur J Contracept Reprod Health Care"}],"container-title":["Seminars in Reproductive Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0045-1811951.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:32:12Z","timestamp":1761607932000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0045-1811951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":123,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2025,10,27]]},"published-print":{"date-parts":[[2025,6]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0045-1811951","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1526-8004","1526-4564"],"issn-type":[{"value":"1526-8004","type":"print"},{"value":"1526-4564","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}